List of Tables
Table 1. Global Bidirectional Immunomodulator Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Bidirectional Immunomodulator Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Bidirectional Immunomodulator Market Competitive Situation by Manufacturers in 2025
Table 4. Global Bidirectional Immunomodulator Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Bidirectional Immunomodulator Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Bidirectional Immunomodulator Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Bidirectional Immunomodulator Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Bidirectional Immunomodulator Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Bidirectional Immunomodulator, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Bidirectional Immunomodulator, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Bidirectional Immunomodulator, Product Types and Applications
Table 12. Global Key Manufacturers of Bidirectional Immunomodulator, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bidirectional Immunomodulator Companies by Tier (Tier 1, Tier 2, Tier 3), based on Bidirectional Immunomodulator Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bidirectional Immunomodulator Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Bidirectional Immunomodulator Sales by Region (K Units), 2021–2026
Table 18. Global Bidirectional Immunomodulator Sales Market Share by Region (2021–2026)
Table 19. Global Bidirectional Immunomodulator Sales by Region (K Units), 2027–2032
Table 20. Global Bidirectional Immunomodulator Sales Market Share by Region (2027–2032)
Table 21. Global Bidirectional Immunomodulator Revenue by Region (US$ Million), 2021–2026
Table 22. Global Bidirectional Immunomodulator Revenue Market Share by Region (2021–2026)
Table 23. Global Bidirectional Immunomodulator Revenue by Region (US$ Million), 2027–2032
Table 24. Global Bidirectional Immunomodulator Revenue Market Share by Region (2027–2032)
Table 25. North America Bidirectional Immunomodulator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Bidirectional Immunomodulator Sales by Country (K Units), 2021–2026
Table 27. North America Bidirectional Immunomodulator Sales by Country (K Units), 2027–2032
Table 28. North America Bidirectional Immunomodulator Revenue by Country (US$ Million), 2021–2026
Table 29. North America Bidirectional Immunomodulator Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Bidirectional Immunomodulator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Bidirectional Immunomodulator Sales by Country (K Units), 2021–2026
Table 32. Europe Bidirectional Immunomodulator Sales by Country (K Units), 2027–2032
Table 33. Europe Bidirectional Immunomodulator Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Bidirectional Immunomodulator Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Bidirectional Immunomodulator Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Bidirectional Immunomodulator Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Bidirectional Immunomodulator Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Bidirectional Immunomodulator Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Bidirectional Immunomodulator Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Bidirectional Immunomodulator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Bidirectional Immunomodulator Sales by Country (K Units), 2021–2026
Table 42. Latin America Bidirectional Immunomodulator Sales by Country (K Units), 2027–2032
Table 43. Latin America Bidirectional Immunomodulator Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Bidirectional Immunomodulator Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Bidirectional Immunomodulator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Bidirectional Immunomodulator Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Bidirectional Immunomodulator Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Bidirectional Immunomodulator Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Bidirectional Immunomodulator Revenue by Country (US$ Million), 2027–2032
Table 50. Global Bidirectional Immunomodulator Sales (K Units) by Type (2021–2026)
Table 51. Global Bidirectional Immunomodulator Sales (K Units) by Type (2027–2032)
Table 52. Global Bidirectional Immunomodulator Sales Market Share by Type (2021–2026)
Table 53. Global Bidirectional Immunomodulator Sales Market Share by Type (2027–2032)
Table 54. Global Bidirectional Immunomodulator Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Bidirectional Immunomodulator Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Bidirectional Immunomodulator Revenue Market Share by Type (2021–2026)
Table 57. Global Bidirectional Immunomodulator Revenue Market Share by Type (2027–2032)
Table 58. Global Bidirectional Immunomodulator Price (US$/Unit) by Type (2021–2026)
Table 59. Global Bidirectional Immunomodulator Price (US$/Unit) by Type (2027–2032)
Table 60. Global Bidirectional Immunomodulator Sales (K Units) by Application (2021–2026)
Table 61. Global Bidirectional Immunomodulator Sales (K Units) by Application (2027–2032)
Table 62. Global Bidirectional Immunomodulator Sales Market Share by Application (2021–2026)
Table 63. Global Bidirectional Immunomodulator Sales Market Share by Application (2027–2032)
Table 64. Global Bidirectional Immunomodulator Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Bidirectional Immunomodulator Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Bidirectional Immunomodulator Revenue Market Share by Application (2021–2026)
Table 67. Global Bidirectional Immunomodulator Revenue Market Share by Application (2027–2032)
Table 68. Global Bidirectional Immunomodulator Price (US$/Unit) by Application (2021–2026)
Table 69. Global Bidirectional Immunomodulator Price (US$/Unit) by Application (2027–2032)
Table 70. Zhifei Biological Company Information
Table 71. Zhifei Biological Description and Business Overview
Table 72. Zhifei Biological Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Zhifei Biological Bidirectional Immunomodulator Product
Table 74. Zhifei Biological Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novartis Bidirectional Immunomodulator Product
Table 79. Novartis Recent Developments/Updates
Table 80. Takeda Pharmaceuticals Company Information
Table 81. Takeda Pharmaceuticals Description and Business Overview
Table 82. Takeda Pharmaceuticals Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Takeda Pharmaceuticals Bidirectional Immunomodulator Product
Table 84. Takeda Pharmaceuticals Recent Developments/Updates
Table 85. Bristol Myers Squibb Company Information
Table 86. Bristol Myers Squibb Description and Business Overview
Table 87. Bristol Myers Squibb Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Bristol Myers Squibb Bidirectional Immunomodulator Product
Table 89. Bristol Myers Squibb Recent Developments/Updates
Table 90. Pfizer Company Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Pfizer Bidirectional Immunomodulator Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Merck Bidirectional Immunomodulator Product
Table 99. Merck Recent Developments/Updates
Table 100. Roche Company Information
Table 101. Roche Description and Business Overview
Table 102. Roche Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Roche Bidirectional Immunomodulator Product
Table 104. Roche Recent Developments/Updates
Table 105. Amgen Company Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Amgen Bidirectional Immunomodulator Product
Table 109. Amgen Recent Developments/Updates
Table 110. Gilead Sciences Company Information
Table 111. Gilead Sciences Description and Business Overview
Table 112. Gilead Sciences Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Gilead Sciences Bidirectional Immunomodulator Product
Table 114. Gilead Sciences Recent Developments/Updates
Table 115. Regeneron Pharmaceuticals Company Information
Table 116. Regeneron Pharmaceuticals Description and Business Overview
Table 117. Regeneron Pharmaceuticals Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Regeneron Pharmaceuticals Bidirectional Immunomodulator Product
Table 119. Regeneron Pharmaceuticals Recent Developments/Updates
Table 120. AstraZeneca Company Information
Table 121. AstraZeneca Description and Business Overview
Table 122. AstraZeneca Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. AstraZeneca Bidirectional Immunomodulator Product
Table 124. AstraZeneca Recent Developments/Updates
Table 125. AbbVie Company Information
Table 126. AbbVie Description and Business Overview
Table 127. AbbVie Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. AbbVie Bidirectional Immunomodulator Product
Table 129. AbbVie Recent Developments/Updates
Table 130. GSK Company Information
Table 131. GSK Description and Business Overview
Table 132. GSK Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. GSK Bidirectional Immunomodulator Product
Table 134. GSK Recent Developments/Updates
Table 135. Boehringer Ingelheim Company Information
Table 136. Boehringer Ingelheim Description and Business Overview
Table 137. Boehringer Ingelheim Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Boehringer Ingelheim Bidirectional Immunomodulator Product
Table 139. Boehringer Ingelheim Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Bidirectional Immunomodulator Distributors List
Table 143. Bidirectional Immunomodulator Customers List
Table 144. Bidirectional Immunomodulator Market Trends
Table 145. Bidirectional Immunomodulator Market Drivers
Table 146. Bidirectional Immunomodulator Market Challenges
Table 147. Bidirectional Immunomodulator Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bidirectional Immunomodulator
Figure 2. Global Bidirectional Immunomodulator Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Bidirectional Immunomodulator Market Share by Type: 2025 & 2032
Figure 4. Rapamycin Product Picture
Figure 5. Bortezomib Product Picture
Figure 6. Thalidamide and Its Derivatives Product Picture
Figure 7. Dexamethasone Product Picture
Figure 8. Other Product Picture
Figure 9. Global Bidirectional Immunomodulator Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Bidirectional Immunomodulator Market Share by Application: 2025 & 2032
Figure 11. Cancer
Figure 12. Autoimmune Diseases
Figure 13. Other
Figure 14. Global Bidirectional Immunomodulator Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Bidirectional Immunomodulator Market Size (US$ Million), 2021–2032
Figure 16. Global Bidirectional Immunomodulator Sales (K Units), 2021–2032
Figure 17. Global Bidirectional Immunomodulator Average Price (US$/Unit), 2021–2032
Figure 18. Bidirectional Immunomodulator Report Years Considered
Figure 19. Bidirectional Immunomodulator Sales Share by Manufacturers in 2025
Figure 20. Global Bidirectional Immunomodulator Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Bidirectional Immunomodulator Players: Market Share by Revenue in Bidirectional Immunomodulator in 2025
Figure 22. Bidirectional Immunomodulator Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Bidirectional Immunomodulator Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Bidirectional Immunomodulator Sales Market Share by Country (2021–2032)
Figure 25. North America Bidirectional Immunomodulator Revenue Market Share by Country (2021–2032)
Figure 26. United States Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Bidirectional Immunomodulator Sales Market Share by Country (2021–2032)
Figure 29. Europe Bidirectional Immunomodulator Revenue Market Share by Country (2021–2032)
Figure 30. Germany Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Bidirectional Immunomodulator Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Bidirectional Immunomodulator Revenue Market Share by Region (2021–2032)
Figure 37. China Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Bidirectional Immunomodulator Sales Market Share by Country (2021–2032)
Figure 45. Latin America Bidirectional Immunomodulator Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Bidirectional Immunomodulator Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Bidirectional Immunomodulator Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Bidirectional Immunomodulator Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Bidirectional Immunomodulator by Type (2021–2032)
Figure 56. Global Revenue Market Share of Bidirectional Immunomodulator by Type (2021–2032)
Figure 57. Global Bidirectional Immunomodulator Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Bidirectional Immunomodulator by Application (2021–2032)
Figure 59. Global Revenue Market Share of Bidirectional Immunomodulator by Application (2021–2032)
Figure 60. Global Bidirectional Immunomodulator Price (US$/Unit) by Application (2021–2032)
Figure 61. Bidirectional Immunomodulator Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
